Free Trial
TSE:TLRY

Tilray Brands (TLRY) Stock Price, News & Analysis

Tilray Brands logo
C$1.90 -0.07 (-3.55%)
(As of 11/15/2024 ET)

About Tilray Brands Stock (TSE:TLRY)

Key Stats

Today's Range
C$1.87
C$1.94
50-Day Range
C$1.90
C$2.48
52-Week Range
C$1.87
C$4.00
Volume
1.43 million shs
Average Volume
1.45 million shs
Market Capitalization
C$1.66 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$2.95
Consensus Rating
N/A

Company Overview

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Tilray Brands Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
14th Percentile Overall Score

TLRY MarketRank™: 

Tilray Brands scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tilray Brands is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tilray Brands is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tilray Brands has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for TLRY.
  • Dividend Yield

    Tilray Brands does not currently pay a dividend.

  • Dividend Growth

    Tilray Brands does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for TLRY.
  • News Sentiment

    Tilray Brands has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Tilray Brands this week, compared to 2 articles on an average week.
  • Search Interest

    Only 24 people have searched for TLRY on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tilray Brands insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.69% of the stock of Tilray Brands is held by insiders.

  • Percentage Held by Institutions

    Only 11.19% of the stock of Tilray Brands is held by institutions.

  • Read more about Tilray Brands' insider trading history.
Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray Brands and its competitors with MarketBeat's FREE daily newsletter.

TLRY Stock News Headlines

When it comes to NVDA… “acceleration cycles” are the key
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Tilray’s SweetWater Brewing unveils headliners for 420 Fest
An Overview of Tilray Brands's Earnings
See More Headlines

TLRY Stock Analysis - Frequently Asked Questions

Tilray Brands' stock was trading at C$3.06 at the start of the year. Since then, TLRY stock has decreased by 37.9% and is now trading at C$1.90.
View the best growth stocks for 2024 here
.

Shares of TLRY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include Meta Platforms (META), Enbridge (ENB), NVIDIA (NVDA), PayPal (PYPL), Enterprise Products Partners (EPD), Palantir Technologies (PLTR) and Tesla (TSLA).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
2,650
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.95
High Stock Price Target
C$2.95
Low Stock Price Target
C$2.95
Potential Upside/Downside
+55.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
C$-244,980,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$788.94 million
Cash Flow
C$0.32 per share
Book Value
C$4.14 per share

Miscellaneous

Free Float
N/A
Market Cap
C$1.66 billion
Optionable
Not Optionable
Beta
2.19
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (TSE:TLRY) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners